Related Experiment Video
Updated: Jul 29, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Rhein Induces Oral Cancer Cell Apoptosis and ROS via Suppresse AKT/mTOR Signaling Pathway In Vitro and In Vivo
Haibo Zhang1,2,3, Lei Ma1,2, Eungyung Kim1,2
1Department of Animal Science and Biotechnology, Kyungpook National University, Sangju 37224, Republic of Korea.
Abstract:
Oral cancer remains the leading cause of death worldwide. Rhein is a natural compound extracted from the traditional Chinese herbal medicine rhubarb, which has demonstrated therapeutic effects in various cancers. However, the specific effects of rhein on oral cancer are still unclear. This study aimed to investigate the potential anticancer activity and underlying mechanisms of rhein in oral cancer cells. The antigrowth effect of rhein in oral cancer cells was estimated by cell proliferation, soft agar colony formation, migration, and invasion assay. The cell cycle and apoptosis were detected by flow cytometry. The underlying mechanism of rhein in oral cancer cells was explored by immunoblotting. The in vivo anticancer effect was evaluated by oral cancer xenografts. Rhein significantly inhibited oral cancer cell growth by inducing apoptosis and S-phase cell cycle arrest. Rhein inhibited oral cancer cell migration and invasion through the regulation of epithelial-mesenchymal transition-related proteins. Rhein induced reactive oxygen species (ROS) accumulation in oral cancer cells to inhibit the AKT/mTOR signaling pathway. Rhein exerted anticancer activity in vitro and in vivo by inducing oral cancer cell apoptosis and ROS via the AKT/mTOR signaling pathway in oral cancer. Rhein is a potential therapeutic drug for oral cancer treatment.
Insights
Rhein, a natural compound, effectively inhibits oral cancer growth by inducing apoptosis and cell cycle arrest. It also reduces migration and invasion by targeting key proteins and the AKT/mTOR pathway, showing potential as an oral cancer therapeutic.
Area of Science:
- Oncology
- Natural Products Chemistry
- Molecular Biology
Background:
- Oral cancer presents a significant global health challenge with high mortality rates.
- Rhein, a compound from rhubarb, shows promise in cancer therapy, but its role in oral cancer requires elucidation.
Purpose of the Study:
- To investigate the anticancer effects of rhein on oral cancer cells.
- To explore the underlying molecular mechanisms of rhein's action in oral cancer.
Main Methods:
- Cell proliferation, soft agar colony formation, migration, and invasion assays were used to assess anti-growth effects.
- Flow cytometry analyzed cell cycle and apoptosis, while immunoblotting explored molecular mechanisms.
- In vivo efficacy was evaluated using oral cancer xenograft models.
Main Results:
- Rhein significantly inhibited oral cancer cell growth, inducing apoptosis and S-phase cell cycle arrest.
- Rhein suppressed oral cancer cell migration and invasion by modulating epithelial-mesenchymal transition (EMT) proteins.
- Rhein promoted reactive oxygen species (ROS) accumulation, inhibiting the AKT/mTOR signaling pathway.
Conclusions:
- Rhein demonstrates potent in vitro and in vivo anticancer activity against oral cancer.
- The mechanism involves inducing apoptosis and ROS via the AKT/mTOR pathway, leading to cell cycle arrest.
- Rhein is a promising therapeutic candidate for oral cancer treatment.
More Related Videos
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
07:38Radiation Treatment of Organotypic Cultures from Submandibular and Parotid Salivary Glands Models Key In Vivo Characteristics
Published on: May 17, 2019
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Abnormal Proliferation
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
MAPK Signaling Cascades
The JAK-STAT Signaling Pathway